The exciting journey of progress: Exploring FIGO 2023 staging for endometrial cancer at a leading ESGO institution
The FIGO 2023 staging system is gaining importance as recent studies highlight the role of molecular classification in prognosis and personalized therapy. Updating our study's follow-up data will clarify its impact in clinical practice.
Authors
- Lorenza Driul (ORCID: https://orcid.org/0000-0003-1896-9410)
- Stefano Restaino (ORCID: https://orcid.org/0000-0002-7848-0329)
- Giorgio Bogani (ORCID: https://orcid.org/0000-0001-8373-8569)
- Giovanni Scambia (ORCID: https://orcid.org/0000-0002-9503-9041)
- Alice Poli
- Antonino Ditto (ORCID: https://orcid.org/0000-0002-5684-8225)
- Giuseppe Vizzielli (ORCID: https://orcid.org/0000-0002-2424-2691)
- Martina Arcieri (ORCID: https://orcid.org/0000-0002-8257-0618)
- Tommaso Occhiali (ORCID: https://orcid.org/0000-0002-0316-1008)
- Andrea Mariani
Institutions
- Università Cattolica del Sacro Cuore (IT)
- University of Udine (IT)
- University of Sassari (IT)
- Mayo Clinic in Arizona (US)
- Ospedale Santa Maria della Misericordia di Udine (IT)
- Centro di Riferimento Oncologico (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
Publication Details
- Journal
- European Journal of Surgical Oncology
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1016/j.ejso.2025.109695
- Citations
- 7
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 14.40